malignant mouse leucocytes, up to 100 per cent of the target cells being killed (Gorer and O'Gormaan, 1956 ). Other tumours have been found by these authors to be less sensitive to the cytotoxic activity of iso-antisera, for example the C3H sarcoma BP8 is only partially affected, not more than 60 per cent of the target cells dying after contact. Sarcoma I, on the other hand, has been found to be completely insensitive to the cytotoxic activity of iso-antisera in vitro, there being ino more non-viable cells in the suspensions treated with antibody than in the normal serum controls (about 5 per cent in each case). The relative susceptibility of three ascites tumours Sal, BP8 and the leukosis EL4, to one cytotoxic antiserum is shown in Table I . The serum was BALB/c anti-BP8 which contains an antibody against an H-2 component, anitigen E, which is common to all three tumours (O'Gorman, 1960) . It seemed possible that this apparent complete insensitivity of Sal to cytotoxic antibody might be due to some antigenic deficiency on the part of the sarcoma cells. The work now to be reported, in which iso-antisera were absorbed with various tumours and normal liver, and then titrated for residual cytotoxic or haemagglutinating activity, was undertaken to test this theory. It has formed part of a thesis submitted to the University of London for the degree of Doctor of Medicine.
Serological techniques.-l. The human serum: dextran system described by Gorer and Mikulska (1954) was used for the experiments using haemagglutination.
2. The cytotoxic technique described by Gorer and O'Gorman (1956) and modified by O'Gorman (1960) was used for the cytotoxic experiments. Guineapig serum was used to provide complement and trypan blue (1/2000 in Ringer's solution) was the dye.
Mice.-Animals were used from the four inbred lines Strain A, BALB/c, C3H
and C57B1, and also the so-called E-B+ (H-2g) cross-over, all maintained in the laboratory of Dr. P. A. Gorer.
Tumours.-Two sarcomata were used, Sarcoma I (A strain) and BP8 (C3H), and one leukosis, EL4 (C57B1). All three are ascites tumours and will sometimes grow progressively if inoculated intra-peritoneally in large doses, in foreign strains, although they are strain specific when smaller doses are given subcutaneously. Suspensions of these tumour cells were made in Ringer's solution in the case of the leukosis and in 3 per cent sodium citrate for the haemorrhagic sarcomata, by puncturing the distended abdomen with a sterile Pasteur pipette, aspirating the contents and ejecting the fluid into the diluent.
RESULTS

A. Experiments using cytotoxic technique
Sera of the type BALB/c anti-C3H contain the cytotoxic antibodies anti-E, anti-K and anti-Dk. Such a serum, BALB/c anti-BP8, was diluted 1: 4 and absorbed for 75 minutes at 370 C. with equal volumes of BALB/c liver, and packed cells of EL4, BP8 and Sal ascites. The absorbed sera were tested on EL4. The only antibody which was being tested was therefore anti-E. The titre of the unabsorbed serum was 1: 64, and that of the serum absorbed with BALB/c liver was also 1: 64. No residual cytotoxicity was found after absorption with EL4 and BP8, but absorption with Sal left cytotoxic activity up to a titre of 1: 32. Both EL4 and BP8 had therefore absorbed anti-E, as would be expected. Sal, on the other hand, had not absorbed anti-E and the tumour cells were presumed to lack E.
This experiment gave no information as to the amount of anti-E which would be absorbed by normal A cells, and therefore a further experiment was performed in which the same BALB/c anti-C3H serum was absorbed with C liver, A liver and Sal and tested on EL4. The antibody is again anti-E. On this occasion the titre of both the unabsorbed serum and that absorbed with C liver were 1: 128 The results of these absorptions are expressed graphically in Fig. 1 Snell (1957) has reviewed the work on the different types of reaction to tumour grafts, and has propounded a classification of transplantable tumours based on their susceptibility to the action of antibody, dividing them into three classes.
The first includes tumours which are completely susceptible to the action of anIti-body, such as EL4. The second comprises tumours which are partially susceptible, such as 6C3HED, which tend to respond to the action of antibody by enhanced rather than inhibited growth. Sal falls into this group. The third group are those which are quite insensitive to the action of antibody, for example the adenocarcinoma D1905. The results of the extensive absorption experiments reported above show that Sarcoma I growing in the ascites form in the Strain A mice maintained in Dr. Gorer's laboratory possesses about 20 per cent of the antigen E possessed by a corresponding amount of normal A liver; it also possesses less of the K antigen than does A strain liver, but about the same amount of antigen D. There appear to be three possible explanations for this antigenic loss. The first is that all the Sal cells are deficient of the antigens by the same amount, whilst the second is that some 80 per cent of the cells are wholly deficient of antigen E and the remaining 20 per cent carry the normal amount; similarly K might be partially missing II from all the cells, or totally missing from some. The third possibility is that the sarcoma cells are all deficient of these antigens and their apparent presence is due to contamination of the ascites with normal erythrocytes and leucocytes having normal antigenic constitutions. We have no definite evidence for or against any one of these theories but as Sal ascites always contains a proportion of host erythrocytes and leucocytes it seems reasonable to deduce that Sal cells are wholly deficient of antigens E and K, and that the small amounts found are due to the normal cells in the ascites. We can only speculate upon the possible relationship between this antigenic loss and the readiness with which the growth of Sal may be enhanced by the action of antibody on the one hand, and on other, the insensitivity of Sal cells to the in vitro toxic effect. Kaliss (1958) believed that immunological enhancement is due to a direct effect of antibody upon the tumour cells. This is evidently not a toxic but rather a stimulating effect, so that the tumour is altered in some way and is thus better able to withstand and overcome the host's defensive reaction. Sarcoma I may be insensitive to cytotoxic antibody because of its antigenic deficiencies, but this need not preclude a stimulant effect of the antibody on the cell and stimulation of an antigen deficient cell by antibody may lie at the root of the mechanism of immunological enhancement.
SUMMARY
Experiments have been reported which have shown, by means of graduated absorption of iso-antisera, that suspensions of Sal show marked deficiencies of the H-2 antigens E and K, but no deficiency of antigen D. It is possible that these deficiencies are connected with the lack of sensitivity of Sal to cytotoxic antibody and the ease with which the growth of the tumour may be enhanced.
